Stock events for American Healthcare REIT, Inc. (AHR)
In the past six months, American Healthcare REIT's stock has been impacted by several events, including earnings releases, distribution declarations, and CEO medical leave. In March 2026, AHR declared its first-quarter 2026 distribution of $0.25 per share. February 2026 saw the announcement of the company's fourth-quarter and full-year 2025 results, along with the issuance of full-year 2026 guidance. During this period, the stock declined by 1.79% on February 26, 2026, despite an earnings beat, and was trading near its 52-week high. Also in February 2026, American Healthcare REIT announced that its CEO and President, Danny Prosky, would take a medical leave of absence, which saw a +2.88% change in stock price. The company also presented at the Citi 2026 Global Property CEO Conference in February 2026. In November 2025, AHR released its third-quarter 2025 earnings. Over the past 12 months, the stock has gained 71.5%.
Demand Seasonality affecting American Healthcare REIT, Inc.’s stock price
American Healthcare REIT experiences demand seasonality, with skilled nursing occupancy declining during winter and flu season, while demand for post-acute care skilled nursing increases. The company anticipates higher move-in activity and strengthening demand during spring and summer for its operating portfolio, including independent and assisted living units. Demand across all four segments was expected to remain strong, driven by an aging population. The company has observed increased demand for its diversified portfolio, especially in assisted living and integrated senior health campuses, with occupancy rates for assisted living facilities returning to pre-COVID levels in Q2 2024.
Overview of American Healthcare REIT, Inc.’s business
American Healthcare REIT, Inc. (AHR) is a healthcare-focused real estate investment trust (REIT) that acquires, owns, and operates a diversified portfolio of clinical healthcare real estate. The company operates within the Real Estate sector and the REIT - Healthcare Facilities industry. Its portfolio primarily consists of senior housing communities, skilled nursing facilities, outpatient medical buildings, hospitals, and other healthcare-related facilities. AHR has four reportable business segments: integrated senior health campuses (ISHC), outpatient medical, triple-net leased properties, and senior housing operating properties (SHOP). The integrated senior health campuses and senior housing operating properties segments are key drivers of its operating momentum and growth.
AHR’s Geographic footprint
American Healthcare REIT's portfolio spans across the United States, and it also owns properties in the United Kingdom and the Isle of Man. The company works with regional operating partners in various U.S. markets to manage its senior housing and long-term care assets.
AHR Corporate Image Assessment
American Healthcare REIT has a generally positive standing, indicated by a consensus rating of "Moderate Buy" from analysts and a MarketBeat's MarketRank™ score higher than 82% of evaluated companies. The company has consistently reported strong financial results, including significant same-store net operating income (NOI) growth in its operating segments, and has increased its fiscal year guidance, which generally contributes to a positive market perception. The company's focus on high-demand areas like assisted living and integrated senior health campuses, and its ability to leverage Medicare Advantage reimbursement rates, also reflect positively on its operational strategy and reputation.
Ownership
As of December 2025, American Healthcare REIT, Inc. has 523 institutional owners and shareholders, collectively holding 177.53 million shares, representing 104.6% of its outstanding shares. Major institutional shareholders include Vanguard Group Inc., BlackRock, Inc., Wellington Management Group Llp, Principal Financial Group Inc, State Street Corp, Royal Bank Of Canada, Invesco Ltd., Geode Capital Management, Llc, Fmr Llc, and Alliancebernstein L.p. Insiders hold 0.92% of the stock.
Ask Our Expert AI Analyst
Price Chart
$50.15